These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10352356)

  • 1. Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth.
    Ghirardi M; Nascimbeni R; Villanacci V; Fontana MG; Di Betta E; Salerni B
    Eur Surg Res; 1999; 31(3):272-80. PubMed ID: 10352356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention.
    Lasko CM; Bird RP
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):49-55. PubMed ID: 7894324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats.
    De Filippo C; Caderni G; Bazzicalupo M; Briani C; Giannini A; Fazi M; Dolara P
    Br J Cancer; 1998 Jun; 77(12):2148-51. PubMed ID: 9649126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous development of aberrant crypt foci in F344 rats.
    Furukawa F; Nishikawa A; Kitahori Y; Tanakamaru Z; Hirose M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):197-201. PubMed ID: 12148578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression.
    Tessitore L; Davit A; Sarotto I; Caderni G
    Carcinogenesis; 2000 Aug; 21(8):1619-22. PubMed ID: 10910967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV; Hirose Y; Indranie C; Reddy BS
    Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats.
    Li H; Kramer PM; Lubet RA; Steele VE; Kelloff GJ; Pereira MA
    Cancer Lett; 1999 Dec; 147(1-2):187-93. PubMed ID: 10660105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats.
    Rodrigues MA; Silva LA; Salvadori DM; De Camargo JL; Montenegro MR
    Braz J Med Biol Res; 2002 Mar; 35(3):351-5. PubMed ID: 11887213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology.
    Park HS; Goodlad RA; Wright NA
    Cancer Res; 1997 Oct; 57(20):4507-10. PubMed ID: 9377561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
    Raju J; Patlolla JM; Swamy MV; Rao CV
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
    Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats.
    Parnaud G; Taché S; Peiffer G; Corpet DE
    Cancer Res; 1999 Oct; 59(20):5143-7. PubMed ID: 10537289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen.
    Whiteley LO; Hudson L; Pretlow TP
    Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid.
    Magnuson BA; Bird RP
    Cancer Lett; 1993 Jan; 68(1):15-23. PubMed ID: 8422645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
    Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
    Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon.
    Yamashita N; Minamoto T; Onda M; Esumi H
    Jpn J Cancer Res; 1994 Jul; 85(7):692-8. PubMed ID: 7915263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of tumors arising from large ACF is associated with the MUC5AC expression during rat colon MNNG carcinogenis.
    Maurin N; Forgue-Lafitte ME; Levy P; Zimber A; Bara J
    Int J Cancer; 2007 Feb; 120(3):477-83. PubMed ID: 17066439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.